Registre National des Cancers de l’Enfant

    < 1 y    1 - 4 y   5 - 9 y   10 - 14 y  
Diagnostic groups and subgroups N/y IR N/y IR N/y IR N/y IR
I. Leukemias, myeloproliferative diseases, and myelodysplastic diseases 28 35.7 222 71.5 150 38.3 116 29.4
Ia. Lymphoid leukemias 12 14.5 190 61.2 126 32.1 84 21.4
Ib. Acute myeloid leukemias 12 14.7 24 7.5 16 4.3 22 5.5
II. Lymphomas and reticuloendothelial neoplasms 0 1.1 24 7.5 54 13.8 106 27.1
IIa. Hodgkin lymphomas 0 0.0 4 1.3 16 4.0 66 16.8
IIb. Non-Hodgkin lymphomas (except Burkitt lymphomas) < 1 1.1 8 2.5 18 4.7 28 7.2
IIc.Burkitt lymphomas 0 0.0 12 3.7 20 5.1 12 3.0
III. CNS and miscellaneous intracranial and intraspinal neoplasms 30 38.9 142 46.0 146 37.2 124 31.8
IIIa. Ependymomas and choroid plexus tumors 6 8.4 18 6.1 10 2.4 10 2.6
IIIb. Astrocytomas 8 11.0 62 19.9 56 14.3 42 10.7
IIIc. Intracranial and intraspinal embryonal tumors 8 11.0 32 10.0 32 8.0 12 3.0
IIId. Other gliomas 2 2.1 14 4.5 24 6.1 18 4.6
IIIe. Other specified intracranial and intraspinal neoplasms 4 5.8 16 5.0 24 6.2 40 10.4
IV. Neuroblastomas and other peripheral nervous cell tumors 56 72.8 68 21.7 14 3.4 6 1.5
IVa. Neuroblastomas and ganglioneuroblastomas 56 72.5 68 21.6 12 3.3 4 1.0
V. Retinoblastomas 20 25.8 26 8.2 2 0.5 0 0.0
VI. Renal tumors 14 18.1 56 18.0 22 5.7 6 1.3
VIa. Nephroblastomas and other nonepithelial renal tumors 14 18.1 56 18.0 22 5.5 4 0.9
VII. Hepatic tumors 6 6.8 10 3.0 2 0.5 2 0.7
VIIa. Hepatoblastomas 6 6.6 8 2.8 2 0.4 < 1 0.2
VIII. Malignant bone tumors 0 0.5 4 1.5 22 5.5 56 14.4
VIIIa. Osteosarcomas 0 0.0 < 1 0.2 10 2.6 30 7.4
VIIIc. Ewing tumors and related bone sarcomas < 1 0.3 4 1.2 10 2.5 24 6.2
IX. Soft tissue and other extraosseous sarcomas 12 16.6 38 12.0 32 8.0 30 7.8
IXa. Rhabdomyosarcomas 4 5.3 28 9.1 18 4.7 10 2.6
IXb. Fibrosarcomas, peripheral nerve sheath tumors, and other fibrous neoplasms 4 4.2 0 0.2 2 0.5 2 0.6
IXd. Other specified soft tissue sarcomas 4 5.3 8 2.3 8 2.1 16 3.8
IXe. Unspecified soft tissue sarcomas 2 1.8 2 0.4 2 0.7 4 0.8
X. Germ-cell tumors, trophoblastic tumors, and neoplasms of gonads 12 15.8 12 3.7 10 2.4 28 7.0
Xa. Intracranial and intraspinal germ cell tumors 2 1.6 4 1.4 6 1.5 14 3.5
Xb. Malignant extracranial and extragonadal germ cell tumors 10 12.4 4 1.5 < 1 0.1 2 0.4
Xc. Malignant gonadal germ cell tumors 2 1.8 2 0.8 4 0.8 10 2.7
XI. Other malignant epithelial neoplasms and malignant melanomas 2 2.1 6 2.1 12 3.0 44 11.4
XIb. Thyroid carcinomas < 1 0.3 2 0.7 4 0.8 16 4.2
XId. Malignant melanomas 0 0.0 2 0.5 4 0.8 6 1.7
XII. Other and unspecified malignant neoplasms 2 2.1 2 0.6 0 0.2 < 1 0.1
All cancers (excluding LCH) 180 236.3 608 195.8 464 118.3 518 132.5
Langherhans cell histiocytosis (LCH) 2 3.7 4 1.3 < 1 0.1 0 0.0
All cancers (including LCH) 182 240.0 612 197.1 464 118.4 518 132.5

Annual number of cases (N), age specific annual incidence rates (IR), mainland France 2010-2014.

Villejuif

INSERM
UMRS1153 Equipe 7
Bâtiment 15/16
16 avenue Paul Vaillant Couturier
94807 Villejuif Cedex

+33 (0)1 45 59 50 37
rnhe@inserm.fr

Nancy

Faculté de Médecine
BP 20199
9 avenue de la Forêt de Haye
54505 Vandoeuvre les Nancy Cedex

+33 (0)3 72 74 63 26
rntse@inserm.fr